DNER and neoplasm: BETs inhibition down-regulates key oncogenic transcription factor pathways, thereby providing anti-tumor activity.143–145 Furthermore, BET-mediated innate and adaptive immune responses contribute to the development of cancers through the regulation of multiple events in the tumor microenvironment (TME), especially chronic inflammation and immune surveillance.